Found 40 matching trials
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 PHASE2 This is a Phase II multi-center trial single arm trial of autologous transp...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Response-based Treatment of High-risk Neuroblastoma PHASE2 The purpose of this study is to improve outcome of high risk neuroblastoma ...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 Based on the further need to improve progression-free survival (PFS) and ov...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor PHASE2 The purpose of this study is to evaluate the outcome of intracranial non-ge...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant NA There is no study hypothesis. The purpose of this study is to see if the Pn...
Show More Location
H.Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission PHASE3 This phase III trial studies rituximab after stem cell transplant and to se...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment PHASE2 Children with relapsed or refractory Hodgkin lymphoma receive 3-6 cycles of...
Show More Status
Enrolling By Invitation
Location
N. N. Blokhin Russian Cancer Research Center, Moscow, Russia
Learn More & Join Trial
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) PHASE3 The study is designed as a Phase III, multi-center trial of tandem autologo...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Tandem Auto-Allo Transplant for Lymphoma PHASE2 Relapse remains a principle cause of treatment failure for patients with ag...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD) PHASE2 In this study, researchers want to find out if using the VTD regimen, along...
Show More Location
University of Arkansas for Medical Sciences
Learn More & Join Trial